Moderna’s stock price is climbing after Health Canada approved its updated COVID-19 vaccine, SPIKEVAX, targeting the KP.2 variant. The approval comes as COVID-19 infections are on the rise, highlighting the importance of staying up-to-date with vaccinations.
Results for: Health Canada
Moderna’s new manufacturing facility in Laval, Quebec, has secured a Drug Establishment License from Health Canada, marking a significant step towards the company’s goal of producing mRNA vaccines within Canada. The site will begin manufacturing a range of respiratory vaccines, including COVID-19, RSV, and influenza, beginning in 2025.